Selank is a synthetic hexapeptide-derived regulatory neuropeptide engineered from the naturally occurring immunomodulating fragment tuftsin. Investigated extensively in preclinical models, this compound serves as a primary tool for evaluating neuro-immune crosstalk, central neurotransmitter turnover, and gene transcription alterations in laboratory settings.
Selank is a synthetic hexapeptide-derived regulatory neuropeptide engineered from the naturally occurring immunomodulating fragment tuftsin. Investigated extensively in preclinical models, this compound serves as a primary tool for evaluating neuro-immune crosstalk, central neurotransmitter turnover, and gene transcription alterations in laboratory settings.
Selank is a synthetic regulatory neuropeptide synthesized by extending the sequence of the naturally occurring human immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg) with a C-terminal Pro-Gly-Pro tripeptide motif. This chemical modification yields the heptapeptide sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, which exhibits enhanced enzymatic resistance against circulating carboxypeptidases and endopeptidases compared to its parent fragment.
In scientific literature, the selank research peptide is categorized as a regulatory neuropeptide investigated primarily in preclinical neuropeptide models for its distinct GABAergic, serotonergic, and immune-signaling effects. Researchers utilize this synthetic sequence to interrogate the molecular cascades linking central nervous system signaling with peripheral immune modulations, as well as transcriptomic shifts in neurotrophic factor expression within rodent and cellular models.
The molecular architecture of Selank relies on the foundational sequence of tuftsin, an endogenous tetrapeptide derived from the Fc domain of immunoglobulin G (IgG). Native tuftsin plays a well-characterized role in phagocytic stimulation and innate immune activation. However, native tuftsin exhibits a rapid biological half-life in aqueous media due to swift cleavage by serum proteases.
By appending the Pro-Gly-Pro sequence to the C-terminus, structural biologists successfully stabilized the peptide chain against immediate enzymatic degradation. This metabolic stabilization allows researchers studying the tuftsin pathway family to observe extended receptor interaction kinetics in vitro. The added proline residues impose conformational rigidity, altering the tertiary binding characteristics and enabling dual interaction with both immune and neural receptor complexes.
Preclinical investigations demonstrate that Selank interacts directly and indirectly with the gamma-aminobutyric acid (GABA) system. In vitro binding assays indicate that while Selank does not bind directly to the primary GABA recognition site, it acts as an allosteric modulator of the GABA-A receptor complex. This modulation influences affinity characteristics for endogenous GABA, altering chloride ion channel kinetics in cultured hippocampal neurons.
Simultaneously, rodent research models demonstrate significant shifts in monoamine metabolism following peptide administration. Experiments measuring tissue levels of monoamines reveal altered serotonin (5-HT) synthesis rates and modified 5-HIAA/5-HT turnover ratios in the prefrontal cortex and hypothalamus. Additionally, data show downstream upregulation of Brain-Derived Neurotrophic Factor (BDNF) mRNA expression in neuronal cell cultures, highlighting a multi-faceted transcriptomic response to the compound within neuroprotective research frameworks.
Given its derivation from tuftsin, Selank retains potent regulatory effects on immune cell lineages. In vitro assays using peripheral blood mononuclear cells (PBMCs) demonstrate that the peptide modulates the expression profile of key inflammatory and regulatory cytokines. Studies document specific alterations in the gene expression and secretion of Interleukin-6 (IL-6), Interleukin-10 (IL-10), and Tumor Necrosis Factor-alpha (TNF-alpha).
This dual action on both central neurotransmitters and systemic cytokine networks makes the compound a central target in neuroimmunology. Researchers investigating all regulatory peptides utilize Selank to map how neuropeptides signal across the blood-brain barrier surrogate models and modulate microglial activation states under stress-induced experimental conditions.
Understanding where Selank sits within regulatory neuropeptide research requires comparing it to structurally and functionally related molecules. While native tuftsin serves strictly as an immunomodulatory sequence with rapid clearance, synthetic derivatives introduce systemic stability and central activity. The table below outlines key structural and mechanistical differences among primary research subjects in this class.
Within comparative literature, researchers often contrast the selank research peptide with the ACTH-derived fragment semax research peptide and the baseline parent molecule tuftsin structural analog. While Semax acts primarily via melanocortin receptors and neurotrophin expression (BDNF/NGF), Selank exhibits pronounced GABAergic allosteric activity paired with tuftsin-like cytokine modulation, providing a unique dual-mechanism profile for comparative neuro-immune assays.
To preserve the structural integrity of Selank during laboratory evaluations, strict reconstituted handling protocols must be maintained. The peptide is supplied as a lyophilized (freeze-dried) white powder requiring precise solubilization procedures. Researchers should calculate solvent volumes based on desired molarity using the verified molecular weight (851.95 g/mol).
Reconstitution should be performed using sterile Bacteriostatic Water or phosphate-buffered saline (PBS, pH 7.4). Solvents should be allowed to run gently down the inner glass wall of the vial rather than being forced directly onto the lyophilized cake. Vials must be gently swirled—never vortexed or vigorously shaken—to prevent mechanical shear stress that can disrupt the peptide backbone. For long-term stability in ongoing assays, reconstituted aliquots should be frozen immediately at -20°C or -80°C to minimize freeze-thaw degradation cycles.
Rigorous laboratory experimentation requires high chemical purity and verifiable composition. Every batch of PX1 Research material undergoes strict analytical verification prior to distribution. Purity is validated via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring a baseline chemical purity exceeding 98%. Chromatograms confirm the absence of truncated sequences, residual reagents, or peptide degradation products.
Mass identity is verified via Electrospray Ionization Mass Spectrometry (ESI-MS), confirming the correct exact mass of the molecule. Crucially for cell culture and immunological assays, endotoxin contamination must be strictly controlled. PX1 Research subjects all batches to Chromogenic Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain below 0.01 EU/μg, preventing non-specific inflammatory responses in sensitive in vitro environments. Institutional buyers seeking high-volume lots can access complete lot-specific testing records through our wholesale lab portal.
In experimental settings, Selank is introduced across a spectrum of established assay models. In cell culture systems, primary rodent hippocampal neurons or microglial cell lines are exposed to controlled nanomolar to micromolar concentrations to quantify changes in intracellular signaling cascades.
Common analytical endpoints include quantitative reverse transcription PCR (RT-qPCR) to measure changes in BDNF, TrkB, and cytokine mRNA levels, as well as radioligand binding assays to measure displacement or modulation at receptor sites. Advanced protocols utilize electrophysiological patch-clamp recording on brain slice preparations to assess immediate changes in inhibitory postsynaptic currents (IPSCs) mediated by GABAergic pathways. Comprehensive methodologies and data references are maintained within the PX1 research library.
Reliable preclinical outcomes depend entirely on the reproducibility and quality of input reagents. Variations in peptide synthesis, residual trifluoroacetic acid (TFA) content, or moisture levels can skew quantitative assays and introduce significant experimental noise.
PX1 Research provides USA-manufactured research peptides synthesized in accordance with strict cGMP protocols and verified by independent ISO 17025 accredited testing facilities. Every product shipped from our California and Arizona fulfillment hubs includes lot-traceable documentation, offering verified identity, purity, and safety specifications required for rigorous academic and private laboratory research.
What is Selank in laboratory research?
Selank is a synthetic regulatory heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) derived from the immunomodulatory sequence tuftsin. It is studied in preclinical research for its effects on GABAergic signaling, monoamines, and cytokine expression.
How does Selank differ structurally from native tuftsin?
Selank incorporates a C-terminal Pro-Gly-Pro tripeptide sequence added to the baseline tuftsin tetrapeptide (Thr-Lys-Pro-Arg). This addition increases enzymatic stability against proteases in aqueous environments.
What primary neurotransmitter systems are studied with Selank?
Preclinical studies focus primarily on Selank's allosteric modulation of GABA-A receptor complexes, alongside alterations in serotonin (5-HT) metabolism and BDNF mRNA expression.
How should lyophilized Selank be reconstituted for lab use?
Lyophilized Selank should be reconstituted with sterile Bacteriostatic Water or PBS (pH 7.4) by allowing the liquid to slide down the vial wall and gently swirling without vortexing.
What storage conditions maintain Selank stability?
Lyophilized powder should be stored at -20°C. Once reconstituted into liquid solution, aliquots should be stored at -20°C or -80°C to prevent degradation and avoid repeated freeze-thaw cycles.
How is the purity of PX1 Research Selank verified?
Purity is verified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to ensure ≥98% purity, while Electrospray Ionization Mass Spectrometry (ESI-MS) confirms exact molecular weight.
What endotoxin controls are applied to Selank research lots?
Each lot undergoes LAL (Limulus Amebocyte Lysate) assay testing to verify that endotoxin levels are below 0.01 EU/μg, preventing confounding immune reactions in vitro.
Is Selank suitable for human consumption or clinical use?
No. Selank supplied by PX1 Research is strictly for laboratory research use only (in vitro and preclinical models) and is not approved for human or veterinary medical use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.